Original Article Increased Expression of Zinc Finger Protein 267 in Non-Alcoholic Fatty Liver Disease

Total Page:16

File Type:pdf, Size:1020Kb

Original Article Increased Expression of Zinc Finger Protein 267 in Non-Alcoholic Fatty Liver Disease Int J Clin Exp Pathol 2011;4(7):661-666 www.ijcep.com /IJCEP1108019 Original Article Increased expression of Zinc finger protein 267 in non-alcoholic fatty liver disease Bernd Schnabl1,2, Barbara Czech1, Daniela Valletta1, Thomas S Weiss3, Georgi Kirovski1, Claus Hellerbrand1 1Department of Internal Medicine I, University Hospital Regensburg, Germany, 2Department of Medicine, University of California San Diego, La Jolla, CA, USA, 3Center for Liver Cell Research, Department of Pediatrics and Juvenile Medicine, University Hospital Regensburg, Germany Received August 25, 2011; accepted September 10, 2011; Epub September 22, 2011; published October 31, 2011 Abstract: Hepatocellular lipid accumulation is a hallmark of non-alcoholic fatty liver disease (NAFLD), which encom- passes a spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) and ultimately cirrhosis. Zinc finger protein 267 (ZNF267) belongs to the family of Kruppel-like transcription factors, which regulate diverse biological processes that include development, proliferation, and differentiation. We have previously demonstrated that ZNF267 expression is up-regulated in liver cirrhosis and is further increased in hepatocellular carcinoma (HCC). Here, we analyzed the expression of ZNF267 in tissue specimens of NAFLD patients and found a significant up- regulation compared to normal liver tissue. Noteworthy, ZNF267 mRNA was already significantly increased in stea- totic liver tissue without inflammation. In line with this, incubation of primary human hepatocytes with palmitic acid induced a dose-dependent lipid accumulation and corresponding dose-dependent ZNF267 induction in vitro. Further- more, hepatocellular lipid accumulation induced formation of reactive oxygen species (ROS), and also chemically induced ROS formation increased ZNF267 mRNA expression. In summary with previous findings, which revealed ZNF267 as pro-fibrogenic and pro-cancerogenic factor in chronic liver disease, the present study further suggests ZNF267 as promising therapeutic target particularly for NAFLD patients. In addition, it further indicates that hepatic steatosis per se has pathophysiological relevance and should not be considered as benign. Keywords: Non-alcoholic fatty liver disease, Kruppel-like factor, ZNF267 Introduction activates hepatitis B virus gene expression and replication [3]. KLF8 is up-regulated in hepato- The Kruppel-like transcription factor (KLF) family cellular cancer (HCC), promotes tumour inva- is involved in the regulation of diverse aspects sion and indicates a poor prognosis for patients of cellular development, differentiation, growth, with liver cancer [4]. In contrast, KLF6 (also and activation [1]. KLFs contain multiple zinc named human zinc finger 9 (ZF9) or COPEB) is a fingers, which represent one of the most com- tumor suppressor gene for HCC [5,6]. Further- mon DNA binding domains. A zinc finger con- more, KLF6 is up-regulated in association with tains two cysteine and two histidine residues increased steatosis, inflammation, and fibrosis that coordinate a single zinc ion and fold the in non-alcoholic fatty liver disease (NAFLD) domain into a finger-like projection [2]. Seven- [7,8]. teen mammalian KLFs have been identified and some of them have been recognized to be in- One further member of the Kruppel-like zinc volved in numerous disorders such as cancer, finger family is zinc finger protein 267 (ZNF267; obesity, cardiovascular disease, and inflamma- also named human zinc finger 2 or HZF2) [9]. It tory conditions [1]. contains a conserved Kruppel associated box (KRAB) domain in the amino terminal part, KLF proteins are also involved in the develop- which is separated through a linker region from ment and progression of different chronic liver a clustered zinc finger domain [9]. The first zinc disease. For example, Kruppel-like factor 15 finger is followed by three degenerated fingers, ZNF267 in NAFLD and then continues with 13 zinc fingers at the obtained by complexing the appropriate amount carboxy terminus [9]. The function of ZNF267 is of palmitate to BSA. PHH were grown in DMEM widely unknown; its mRNA is up-regulated upon supplemented with penicillin (400 U/ml), strep- nitric oxide treatment in venous endothelial tomycin (50 mg/ml), L-glutamine (300 mg/ml), cells [10], and previously, we have demon- 0.2% FCS and palmitate for 24h in different strated that ZNF267 mRNA is up-regulated in concentrations as indicated. FFA-free-BSA- liver cirrhosis compared to normal human liver treated cells served as controls. tissue [11]. Furthermore, we found that ZNF267 expression is increased in human HCC-cells and To induce ROS formation cells were incubated tissue compared to primary human hepatocytes with 10µM arsenic trioxide (As2O3; Sigma Al- (PHH) and corresponding non-tumorous hepatic drich) as described [12]. liver tissue, respectively [12]. Human tissue Nonalcoholic fatty liver disease (NAFLD) is today recognized as the most common liver disease Human liver specimens from patients were ob- and one of the most frequent causes of liver tained during resection of metastasis of non- cirrhosis [13,14]. Furthermore, NAFLD is a main hepatic tumors. Tissue samples were immedi- risk factor for the development and progression ately snap frozen after surgical resection and of HCC [15]. NAFLD is characterized by lipid stored at -80°C until subsequent analysis. For accumulation in the liver that may progress this study, the following exclusion criteria were from simple hepatic steatosis towards inflam- applied: 1. chronic alcohol abuse (more than 30 mation (non-alcoholic steatohepatitis [NASH]) g/day for men and 20g/day for women), 2. with progressive fibrosis [16,17,18]. medications known to cause hepatic steatosis (at present or within the last 2 years), 3. signifi- NAFLD is strongly associated with the metabolic cant weight loss (more than 3 kg within the last syndrome and its defining pathophysiological 3 months), 4. hepatobiliary diseases, 5. ascites components obesity, diabetes and dyslipidemia. on ultrasound, 6. inflammatory bowel disease, Thus, overeating delivers an excess of triglyc- 7. infection with the human immunodeficiency erides to the liver. Further, peripheral lipolysis in virus or Hepatitis B and C virus, and 8. chemo- obese and insulin resistant states leads to an therapy prior to partial hepatectomy. increased hepatic influx of fatty acids (FA). In addition, hepatic FA synthesis is increased sec- Hepatic steatosis and inflammation was scored ondary to elevated glucose and insulin levels. applying a modified histological score according Together, both uptake of exogenously derived to the recommendations of the Nonalcoholic FA and de novo hepatic synthesis of FA lead to Steatohepatitis Clinical Research Network [26]. an increase of hepatic lipid content, e.g. hepatic Briefly, four histological features were evaluated steatosis [19,20,21]. semi-quantitatively: steatosis (0-3), lobular in- flammation (0-2), hepatocellular ballooning (0- In the present study we aimed to assess the 2), and fibrosis (0-4). Simple steatosis was diag- effect of hepatic steatosis on ZNF267 expres- nosed in the presence of steatosis but the ab- sion in an in vitro model of hepatocellular lipid sence of inflammation, fibrosis and hepatocellu- accumulation [22] and in hepatic specimens of lar ballooning. Steatohepatitis was diagnosed NAFLD patients. when the sum of the scores was 4 or more. Materials and methods Human liver tissue was obtained and experi- mental procedures were performed according to Cells and cell culture the guidelines of the charitable state controlled foundation HTCR, with the informed patient's Isolation and culture of primary human hepato- consent, and the study was approved by the cytes (PHH) were performed as described [23]. local ethics committee of the University Regens- The HCC cell line HepG2 (ATCC HB-8065) was burg. cultured as described previously [24,24]. Hepa- tocellular lipid accumulation was induced as Expression analysis described [25]. Briefly, a 10 mM palmitate/1% bovine serum albumin (BSA) stock solution was Isolation of total cellular RNA from cultured cells 662 Int J Clin Exp Pathol 2011;4(7):661-666 ZNF267 in NAFLD and tissue and reverse transcription were per- formed as described previously [27]. Quantita- tive real-time PCR was performed with primers specific for ZNF267 (forward: 5’- ATG GGA GCT GTG ATC TTG AGA; reverse: 5’-GCA ATG ATG AAT GAG TAA AGA CC), employing LightCycler tech- nology (Roche, Mannheim, Germany) [28]. Detection of ROS Cells were plated in 96-well-plates and cultured in DMEM without phenol red (PAN Biotech GmbH, Aidenbach, Germany). Three hours after treatment with As2O3 or palmitate cells were washed with PBS and were incubated for 30min at 37°C with the redox-sensitive dye 2',7'- dichlorodihydrofluorescein diacetate (H2DCFDA, Figure 1. ZNF267 expression in NAFLD: Expression Invitrogen, Darmstadt, Germany; 100μM). Sub- of ZNF267 mRNA in normal, non steatotic human sequently, ROS formation was detected using a liver tissue compared to steatotic liver tissue without inflammation and NASH specimens analyzed by multiwell fuorescence plate reader (Spectra quantitative real-time PCR (*:p<0.05 compared to Fuor Plus, Tecan, Männedorf, Switzerland) with normal liver tissue). excitation and emission filters of 485 and 535nm, respectively. Statistical analysis lyzed ZNF267 mRNA expression in an in vitro model of hepatocellular lipid accumulation Statistical analyses were performed using which we
Recommended publications
  • Supporting Information for Proteomics DOI 10.1002/Pmic.200401283
    Supporting Information for Proteomics DOI 10.1002/pmic.200401283 Laura Bianchi, Cristina Canton, Luca Bini, Rosaria Orlandi, Sylvie Mnard, Alessandro Armini, Monica Cattaneo, Vitaliano Pallini, Luigi Rossi Bernardi and Ida Biunno Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L gene induction ª 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.de Probe Set ID UniGene ID Representative Public ID Gene Title Gene Symbol E+E- M+M- E+M+ E-M- 38591_at 397073 D38501 postmeiotic segregation increased 2-like 5 PMS2L5 D NC D NC 37611_at 81791 AB008822 tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) TNFRSF11B D NC D NC 40711_at 86405 AL049340 Splicing factor YT521-B YT521 D NC D NC 33540_at 378826 AL049233 Chromosome 10 open reading frame 18 C10orf18 D NC D NC 1298_at 510244 X86816 Estrogen receptor cDNA, 5' splice variant --- D NC D NC 38266_at 188553 W25798 retinoblastoma binding protein 6 RBBP6 D NC D NC 31665_s_at --- W27675 --- --- D NC D NC 40713_at 86998 AB020634 nuclear factor of activated T-cells 5, tonicity-responsive NFAT5 D NC D NC 33658_at 421238 S54641 zinc finger protein 124 (HZF-16) ZNF124 D NC D NC 1465_s_at 300592 S75881 V-myb myeloblastosis viral oncogene homolog (avian)-like 1 MYBL1 D NC D NC 36448_at --- X95677 --- --- D NC D NC 34777_at 441047 D14874 adrenomedullin ADM D NC D NC 32389_at 536594 W25892 Transcribed locus, weakly similar to XP_216369.2 similar to ORF2 consensus sequence encoding endonuclease and reverse--- transcriptase minus
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Figure S1. HAEC ROS Production and ML090 NOX5-Inhibition
    Figure S1. HAEC ROS production and ML090 NOX5-inhibition. (a) Extracellular H2O2 production in HAEC treated with ML090 at different concentrations and 24 h after being infected with GFP and NOX5-β adenoviruses (MOI 100). **p< 0.01, and ****p< 0.0001 vs control NOX5-β-infected cells (ML090, 0 nM). Results expressed as mean ± SEM. Fold increase vs GFP-infected cells with 0 nM of ML090. n= 6. (b) NOX5-β overexpression and DHE oxidation in HAEC. Representative images from three experiments are shown. Intracellular superoxide anion production of HAEC 24 h after infection with GFP and NOX5-β adenoviruses at different MOIs treated or not with ML090 (10 nM). MOI: Multiplicity of infection. Figure S2. Ontology analysis of HAEC infected with NOX5-β. Ontology analysis shows that the response to unfolded protein is the most relevant. Figure S3. UPR mRNA expression in heart of infarcted transgenic mice. n= 12-13. Results expressed as mean ± SEM. Table S1: Altered gene expression due to NOX5-β expression at 12 h (bold, highlighted in yellow). N12hvsG12h N18hvsG18h N24hvsG24h GeneName GeneDescription TranscriptID logFC p-value logFC p-value logFC p-value family with sequence similarity NM_052966 1.45 1.20E-17 2.44 3.27E-19 2.96 6.24E-21 FAM129A 129. member A DnaJ (Hsp40) homolog. NM_001130182 2.19 9.83E-20 2.94 2.90E-19 3.01 1.68E-19 DNAJA4 subfamily A. member 4 phorbol-12-myristate-13-acetate- NM_021127 0.93 1.84E-12 2.41 1.32E-17 2.69 1.43E-18 PMAIP1 induced protein 1 E2F7 E2F transcription factor 7 NM_203394 0.71 8.35E-11 2.20 2.21E-17 2.48 1.84E-18 DnaJ (Hsp40) homolog.
    [Show full text]
  • Strand Breaks for P53 Exon 6 and 8 Among Different Time Course of Folate Depletion Or Repletion in the Rectosigmoid Mucosa
    SUPPLEMENTAL FIGURE COLON p53 EXONIC STRAND BREAKS DURING FOLATE DEPLETION-REPLETION INTERVENTION Supplemental Figure Legend Strand breaks for p53 exon 6 and 8 among different time course of folate depletion or repletion in the rectosigmoid mucosa. The input of DNA was controlled by GAPDH. The data is shown as ΔCt after normalized to GAPDH. The higher ΔCt the more strand breaks. The P value is shown in the figure. SUPPLEMENT S1 Genes that were significantly UPREGULATED after folate intervention (by unadjusted paired t-test), list is sorted by P value Gene Symbol Nucleotide P VALUE Description OLFM4 NM_006418 0.0000 Homo sapiens differentially expressed in hematopoietic lineages (GW112) mRNA. FMR1NB NM_152578 0.0000 Homo sapiens hypothetical protein FLJ25736 (FLJ25736) mRNA. IFI6 NM_002038 0.0001 Homo sapiens interferon alpha-inducible protein (clone IFI-6-16) (G1P3) transcript variant 1 mRNA. Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 GALNTL5 NM_145292 0.0001 (GALNT15) mRNA. STIM2 NM_020860 0.0001 Homo sapiens stromal interaction molecule 2 (STIM2) mRNA. ZNF645 NM_152577 0.0002 Homo sapiens hypothetical protein FLJ25735 (FLJ25735) mRNA. ATP12A NM_001676 0.0002 Homo sapiens ATPase H+/K+ transporting nongastric alpha polypeptide (ATP12A) mRNA. U1SNRNPBP NM_007020 0.0003 Homo sapiens U1-snRNP binding protein homolog (U1SNRNPBP) transcript variant 1 mRNA. RNF125 NM_017831 0.0004 Homo sapiens ring finger protein 125 (RNF125) mRNA. FMNL1 NM_005892 0.0004 Homo sapiens formin-like (FMNL) mRNA. ISG15 NM_005101 0.0005 Homo sapiens interferon alpha-inducible protein (clone IFI-15K) (G1P2) mRNA. SLC6A14 NM_007231 0.0005 Homo sapiens solute carrier family 6 (neurotransmitter transporter) member 14 (SLC6A14) mRNA.
    [Show full text]
  • Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer
    Epigenetic mechanisms are involved in the oncogenic properties of ZNF518B in colorectal cancer Francisco Gimeno-Valiente, Ángela L. Riffo-Campos, Luis Torres, Noelia Tarazona, Valentina Gambardella, Andrés Cervantes, Gerardo López-Rodas, Luis Franco and Josefa Castillo SUPPLEMENTARY METHODS 1. Selection of genomic sequences for ChIP analysis To select the sequences for ChIP analysis in the five putative target genes, namely, PADI3, ZDHHC2, RGS4, EFNA5 and KAT2B, the genomic region corresponding to the gene was downloaded from Ensembl. Then, zoom was applied to see in detail the promoter, enhancers and regulatory sequences. The details for HCT116 cells were then recovered and the target sequences for factor binding examined. Obviously, there are not data for ZNF518B, but special attention was paid to the target sequences of other zinc-finger containing factors. Finally, the regions that may putatively bind ZNF518B were selected and primers defining amplicons spanning such sequences were searched out. Supplementary Figure S3 gives the location of the amplicons used in each gene. 2. Obtaining the raw data and generating the BAM files for in silico analysis of the effects of EHMT2 and EZH2 silencing The data of siEZH2 (SRR6384524), siG9a (SRR6384526) and siNon-target (SRR6384521) in HCT116 cell line, were downloaded from SRA (Bioproject PRJNA422822, https://www.ncbi. nlm.nih.gov/bioproject/), using SRA-tolkit (https://ncbi.github.io/sra-tools/). All data correspond to RNAseq single end. doBasics = TRUE doAll = FALSE $ fastq-dump -I --split-files SRR6384524 Data quality was checked using the software fastqc (https://www.bioinformatics.babraham. ac.uk /projects/fastqc/). The first low quality removing nucleotides were removed using FASTX- Toolkit (http://hannonlab.cshl.edu/fastxtoolkit/).
    [Show full text]
  • Supp Data.Pdf
    Supplementary Methods Verhaak sub-classification The Verhaak called tumor subtype was assigned as determined in the Verhaak et al. manuscript, for those TCGA tumors that were included at the time. TCGA data for expression (Affymetrix platform, level 1) and methylation (Infinium platform level 3) were downloaded from the TCGA portal on 09/29/2011. Affymetrix data were processed using R and Biocondutor with a RMA algorithm using quantile normalization and custom CDF. Level 3 methylation data has already been processed and converted to a beta-value. The genes that make up the signature for each of the 4 Verhaak groups (i.e. Proneural, Neural, Mesenchymal, and Classical) were downloaded. For each tumor, the averaged expression of the 4 genes signatures was calculated generating 4 ‘metagene’ scores, one for each subtype, (Colman et al.2010) for every tumor. Then each subtype metagene score was z-score corrected to allow comparison among the 4 metagenes. Finally, for each tumor the subtype with the highest metagene z-score among the four was used to assign subtype. Thus by this method, a tumor is assigned to the group to which it has the strongest expression signature. The shortcoming is that if a tumor has a ‘dual personality’ – for instance has strong expression of both classical and mesenchymal signature genes, there is some arbitrariness to the tumor’s assignment. Western Blot Analysis and cell fractionation Western blot analysis was performed using standard protocols. To determine protein expression we used the following antibodies: TAZ (Sigma and BD Biosciences), YAP (Santa Cruz Biotechnology), CD44 (Cell Signaling), FN1 (BD Biosciences), TEAD1, TEAD2, TEAD3, TEAD4 (Santa Cruz Biotechnology), MST1, p-MST1, MOB1, LATS1, LATS2, 14-3-3-, 1 ACTG2, (Cell Signaling), p-LATS1/2 (Abcam), Flag (Sigma Aldrich), Actin (Calbiochem), CAV2 (BD Biosciences), CTGF (Santa Cruz), RUNX2 (Sigma Aldrich), Cylin A, Cyclin E, Cyclin B1, p-cdk1, p-cdk4 (Cell Signaling Technologies).
    [Show full text]
  • Single-Cell RNA Landscape of Intratumoral Heterogeneity and Immunosuppressive Microenvironment in Advanced Osteosarcoma
    ARTICLE https://doi.org/10.1038/s41467-020-20059-6 OPEN Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma Yan Zhou1,11, Dong Yang2,11, Qingcheng Yang2,11, Xiaobin Lv 3,11, Wentao Huang4,11, Zhenhua Zhou5, Yaling Wang 1, Zhichang Zhang2, Ting Yuan2, Xiaomin Ding1, Lina Tang 1, Jianjun Zhang1, Junyi Yin1, Yujing Huang1, Wenxi Yu1, Yonggang Wang1, Chenliang Zhou1, Yang Su1, Aina He1, Yuanjue Sun1, Zan Shen1, ✉ ✉ ✉ ✉ Binzhi Qian 6, Wei Meng7,8, Jia Fei9, Yang Yao1 , Xinghua Pan 7,8 , Peizhan Chen 10 & Haiyan Hu1 1234567890():,; Osteosarcoma is the most frequent primary bone tumor with poor prognosis. Through RNA- sequencing of 100,987 individual cells from 7 primary, 2 recurrent, and 2 lung metastatic osteosarcoma lesions, 11 major cell clusters are identified based on unbiased clustering of gene expression profiles and canonical markers. The transcriptomic properties, regulators and dynamics of osteosarcoma malignant cells together with their tumor microenvironment particularly stromal and immune cells are characterized. The transdifferentiation of malignant osteoblastic cells from malignant chondroblastic cells is revealed by analyses of inferred copy-number variation and trajectory. A proinflammatory FABP4+ macrophages infiltration is noticed in lung metastatic osteosarcoma lesions. Lower osteoclasts infiltration is observed in chondroblastic, recurrent and lung metastatic osteosarcoma lesions compared to primary osteoblastic osteosarcoma lesions. Importantly, TIGIT blockade enhances the cytotoxicity effects of the primary CD3+ T cells with high proportion of TIGIT+ cells against osteo- sarcoma. These results present a single-cell atlas, explore intratumor heterogeneity, and provide potential therapeutic targets for osteosarcoma. 1 Oncology Department of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China.
    [Show full text]
  • Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors
    University of Cincinnati Date: 12/20/2010 I, Arturo R Maldonado , hereby submit this original work as part of the requirements for the degree of Doctor of Philosophy in Developmental Biology. It is entitled: Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors Student's name: Arturo R Maldonado This work and its defense approved by: Committee chair: Jeffrey Whitsett Committee member: Timothy Crombleholme, MD Committee member: Dan Wiginton, PhD Committee member: Rhonda Cardin, PhD Committee member: Tim Cripe 1297 Last Printed:1/11/2011 Document Of Defense Form Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors A dissertation submitted to the Graduate School of the University of Cincinnati College of Medicine in partial fulfillment of the requirements for the degree of DOCTORATE OF PHILOSOPHY (PH.D.) in the Division of Molecular & Developmental Biology 2010 By Arturo Rafael Maldonado B.A., University of Miami, Coral Gables, Florida June 1993 M.D., New Jersey Medical School, Newark, New Jersey June 1999 Committee Chair: Jeffrey A. Whitsett, M.D. Advisor: Timothy M. Crombleholme, M.D. Timothy P. Cripe, M.D. Ph.D. Dan Wiginton, Ph.D. Rhonda D. Cardin, Ph.D. ABSTRACT Since 1999, cancer has surpassed heart disease as the number one cause of death in the US for people under the age of 85. Malignant Peripheral Nerve Sheath Tumor (MPNST), a common malignancy in patients with Neurofibromatosis, and colorectal cancer are midkine- producing tumors with high mortality rates. In vitro and preclinical xenograft models of MPNST were utilized in this dissertation to study the role of midkine (MDK), a tumor-specific gene over- expressed in these tumors and to test the efficacy of a MDK-transcriptionally targeted oncolytic HSV-1 (oHSV).
    [Show full text]
  • SUPPLEMENTARY MATERIALS and METHODS PBMC Transcriptomics
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Gut SUPPLEMENTARY MATERIALS AND METHODS PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF Contents l Supplementary methods l Supplementary Figure 1 l Supplementary Figure 2 l Supplementary Figure 3 l Supplementary Figure 4 l Supplementary Figure 5 l Supplementary Table 1 l Supplementary Table 2 l Supplementary Table 3 l Supplementary Table 4 l Supplementary Tables 5-14 l Supplementary Table 15 l Supplementary Table 16 l Supplementary Table 17 Li J, et al. Gut 2021;0:1–13. doi: 10.1136/gutjnl-2020-323395 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Gut SUPPLEMENTARY METHODS Test for HBV DNA The levels of HBV DNA were detected using real-time PCR with a COBAS® AmpliPrep/COBAS® TaqMan 48 System (Roche, Basel, Switzerland) and HBV Test v2.0. Criteria for diagnosing cirrhosis Pathology The gold standard for the diagnosis of cirrhosis is a liver biopsy obtained through a percutaneous or transjugular approach.1 Ultrasonography was performed 2-4 hours before biopsy. Liver biopsy specimens were obtained by experienced physicians. Percutaneous transthoracic puncture of the liver was performed according to the standard criteria. After biopsy, patients were monitored in the hospital with periodic analyses of haematocrit and other vital signs for 24 hours. Cirrhosis was diagnosed according to the globally agreed upon criteria.2 Cirrhosis is defined based on its pathological features under a microscope: (a) the presence of parenchymal nodules, (b) differences in liver cell size and appearance, (c) fragmentation of the biopsy specimen, (d) fibrous septa, and (d) an altered architecture and vascular relationships.
    [Show full text]
  • The Colors in This Table Match the Colored Gene Groups in Figure 2
    Supplementary Table S3 a: The colors in this table match the colored gene groups in Figure 2. Specifically acetylated genes in cHL (n=211) and B-cell lines (B1AC in Figure 2: n=327) determined by the cHL versus B-cell line comparison. Furthermore the 141 genes which were found in the intersection of the two B-cell groups (which are therefore jointly hypoacetylated in cHL and PCM cell lines) are marked in blue. Name Entrez Gene Ref Seq p-value (Acetylation) Ratio SEMA4C 54910 NM_017789.4 3,66E-006 -8,376854452 IL6 3569 NM_000600.2 1,77E-005 -8,314958127 ONECUT2 9480 NM_004852.2 4,00E-006 -8,282444977 IFIH1 64135 NM_022168.2 8,05E-006 -8,148979811 MARCKS 4082 NM_002356.5 3,00E-006 -8,132604423 BATF3 55509 NM_018664.1 5,26E-006 -8,091403371 CISH 1154 NM_145071.1 5,75E-005 -7,96206129 MAPKAPK3 7867 NM_004635.3 3,68E-005 -7,940750902 MEIS1 4211 NM_002398.2 6,76E-006 -7,771709205 FUT4 2526 NM_002033.2 6,72E-006 -7,720048774 CCR7 1236 NM_001838.2 3,01E-006 -7,716010702 ATF3 467 NM_001040619.1 3,97E-006 -7,640583425 IRF4 3662 NM_002460.1 4,87E-006 -7,625499983 BEND6 221336 NM_152731.2 1,33E-005 -7,576292802 EHBP1 23301 NM_015252.2 3,88E-006 -7,560681148 BCL2A1 597 NM_004049.2 1,78E-005 -7,527741084 GPR55 9290 NM_005683.3 8,36E-005 -7,476175621 ARNTL2 56938 NM_020183.3 9,09E-006 -7,464130822 EML4 27436 NM_019063.2 9,11E-006 -7,455394769 FSCN1 6624 NM_003088.2 4,82E-005 -7,434424042 CSF1 1435 NM_000757.3 7,12E-006 -7,421812952 LY75 4065 NM_002349.2 5,42E-006 -7,396251517 VIM 7431 NM_003380.2 3,18E-005 -7,368164191 IRAK1 3654 NM_001569.3 8,59E-006
    [Show full text]
  • STAT3 Targets Suggest Mechanisms of Aggressive Tumorigenesis in Diffuse Large B Cell Lymphoma
    STAT3 Targets Suggest Mechanisms of Aggressive Tumorigenesis in Diffuse Large B Cell Lymphoma Jennifer Hardee*,§, Zhengqing Ouyang*,1,2,3, Yuping Zhang*,4 , Anshul Kundaje*,†, Philippe Lacroute*, Michael Snyder*,5 *Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305; §Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06520; and †Department of Computer Science, Stanford University School of Engineering, Stanford, CA 94305 1The Jackson Laboratory for Genomic Medicine, Farmington, CT 06030 2Department of Biomedical Engineering, University of Connecticut, Storrs, CT 06269 3Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, CT 06030 4Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT 06520 5Corresponding author: Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305. Email: [email protected] DOI: 10.1534/g3.113.007674 Figure S1 STAT3 immunoblotting and immunoprecipitation with sc-482. Western blot and IPs show a band consistent with expected size (88 kDa) of STAT3. (A) Western blot using antibody sc-482 versus nuclear lysates. Lanes contain (from left to right) lysate from K562 cells, GM12878 cells, HeLa S3 cells, and HepG2 cells. (B) IP of STAT3 using sc-482 in HeLa S3 cells. Lane 1: input nuclear lysate; lane 2: unbound material from IP with sc-482; lane 3: material IP’d with sc-482; lane 4: material IP’d using control rabbit IgG. Arrow indicates the band of interest. (C) IP of STAT3 using sc-482 in K562 cells. Lane 1: input nuclear lysate; lane 2: material IP’d using control rabbit IgG; lane 3: material IP’d with sc-482.
    [Show full text]
  • Supplementary Figure S1 A
    Supplementary Figure S1 A B C 1 4 1 3 1 2 1 2 1 0 1 1 (Normalized signal values)] 2 (Normalized signal values) (Normalized 8 2 10 Log 6 AFFX-BioC AFFX-BioB AFFX-BioDn AFFX-CreX hDFs [Log 6 8 10 12 14 hOFs [Log2 (Normalized signal values)] Supplementary Figure S2 GLYCOLYSIS PENTOSE-PHOSPHATE PATHWAY Glucose Purine/pyrimidine Glucose-6-phosphate metabolism AMINO ACID Fluctose-6-phosphate AMPK METABOLISM TIGAR PFKFB2 methylgloxal GloI Ser, Gly, Thr Glyceraldehyde-3-phosphate ALDH Lactate PYRUVATE LDH METABOLISM acetic acid Ethanol Pyruvate GLYCOSPHINGOLIPID NADH BIOSYNTHESIS Ala, Cys DLD PDH PDK3 DLAT Fatty acid Lys, Trp, Leu, Acetyl CoA ACAT2 Ile, Tyr, Phe β-OXIDATION ACACA Citrate Asp, Asn Citrate Acetyl CoA Oxaloacetate Isocitrate MDH1 IDH1 Glu, Gln, His, ME2 TCA Pro, Arg 2-Oxoglutarate MDH1 CYCLE Pyruvate Malate ME2 GLUTAMINOLYSIS FH Succinyl-CoA Fumalate SUCLA2 Tyr, Phe Var, Ile, Met Supplementary Figure S3 Entrez Gene Symbol Gene Name hODs hDFs hOF-iPSCs GeneID 644 BLVRA biliverdin reductase A 223.9 259.3 253.0 3162 HMOX1 heme oxygenase 1 1474.2 2698.0 452.3 9365 KL klotho 54.1 44.8 36.5 nicotinamide 10135 NAMPT 827.7 626.2 2999.8 phosphoribosyltransferase nuclear factor (erythroid- 4780 NFE2L2 2134.5 1331.7 1006.2 derived 2) related factor 2 peroxisome proliferator- 5467 PPARD 1534.6 1352.9 330.8 activated receptor delta peroxisome proliferator- 5468 PPARG 524.4 100.8 63.0 activated receptor gamma 5621 PRNP prion protein 4059.0 3134.1 1065.5 5925 RB1 retinoblastoma 1 882.9 805.8 739.3 23411 SIRT1 sirtuin 1 231.5 216.8 1676.0 7157 TP53
    [Show full text]